| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tuhura Biosciences, Inc./nv (HURA) has 2 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. HURA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 610.3K | $1.55M | - | |
| CFO | 273.7K | $696.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 16, 2015 | Bell John K | Director | Buy | 50,000 | $0.60 | $30,000.00 | +57.5% | |
| Jan 22, 2015 | Bacha Jeffrey | CEO And President | Buy | 7,500 | $0.66 | $4,925.00 | +6.4% |